The Effects of Omega-3 Fatty Acids and Vitamin D Supplementation on the Nutritional Status of Women with Breast Cancer in Palestine: An Open-Label Randomized Controlled Trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

It aimed to assess the effects of omega-3 fatty acids (ω3) and vitamin D3 (VitD) supplementation on the nutritional status of newly diagnosed women with breast cancer (BC) in the Gaza Strip, Palestine.

Why It Was Studied

This study emphasizes the critical role of early nutritional interventions in addressing cancer-related malnutrition.

Who Took Part

According to the abstract, 88 women were involved.

By PubMed's age tags, the people studied were adults and middle-aged adults, women only.

A total of 88 newly diagnosed women with BC were randomly assigned into four groups: (i) Omega-3 fatty acid (ω3) group; (ii) Vitamin D (VitD) group; (iii) ω3+VitD group; and (iv) the controls.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

The procedures of the present study were registered on ClinicalTrial.gov with the identifier NCT05331807.

What Was Measured

Topics PubMed links to this paper include Breast Neoplasms, Nutritional Status, Fatty Acids, Omega-3, Dietary Supplements, Vitamin D, Middle East and Arabs.

The authors tagged it with the keywords anthropometric measurements, blood albumin, breast cancer, dietary intake and omega-3 fatty acids.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 88 women.

Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Nutrients), a journal based in Switzerland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.